Claim
Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease. — PurposeThe BACE inhibitor verubecestat was previously found to reduce amyloid load as assessed by 18F-flutemetamol positron emission tomography (PET) composite cortical...
Sur C et al. 2022, Molecular imaging and biology
Evidence span
Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease. — PurposeThe BACE inhibitor verubecestat was previously found to reduce amyloid load as assessed by 18F-flutemetamol positron emission tomography (PET) composite cortical...
Method & conditions
- Evidence type
- experimental
- Method
- manual state transition; control details require source inspection
- Species
- Homo sapiens
- Conditions
- Brain; Humans; Alzheimer Disease; Amyloidosis; Aniline Compounds — Molecular imaging and biology 2022
- Replicated
- not yet
Confidence basis
operator-supplied frontier prior; review required